Genomadix’s CEO says the Ottawa biotech firm that rose from the ashes of Spartan Bioscience should start turning a profit by next year after recently signing a deal to license some of its IP to a New Brunswick company. Fredericton-based LuminUltra, which specializes in technology that rapidly identifies microbes that can cause legionnaires’ disease and […]
Already an Insider? Log in
Get Instant Access to This Article
Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.
- Critical Ottawa business news and analysis updated daily.
- Immediate access to all Insider-only content on our website.
- 4 issues per year of the Ottawa Business Journal magazine.
- Special bonus issues like the Ottawa Book of Lists.
- Discounted registration for OBJ’s in-person events.
Click here to purchase a paywall bypass link for this article.